参考文章(13)
Xiao Chen, Rupali Das, Richard Komorowski, Amy Beres, Martin J. Hessner, Masahiko Mihara, William R. Drobyski, Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease. Blood. ,vol. 114, pp. 891- 900 ,(2009) , 10.1182/BLOOD-2009-01-197178
Chandrashekhar Pasare, Ruslan Medzhitov, Toll Pathway-Dependent Blockade of CD4+CD25+ T Cell-Mediated Suppression by Dendritic Cells Science. ,vol. 299, pp. 1033- 1036 ,(2003) , 10.1126/SCIENCE.1078231
Ran Reshef, Selina M. Luger, Elizabeth O. Hexner, Alison W. Loren, Noelle V. Frey, Sunita D. Nasta, Steven C. Goldstein, Edward A. Stadtmauer, Jacqueline Smith, Sarah Bailey, Rosemarie Mick, Daniel F. Heitjan, Stephen G. Emerson, James A. Hoxie, Robert H. Vonderheide, David L. Porter, Blockade of Lymphocyte Chemotaxis in Visceral Graft-versus-Host Disease The New England Journal of Medicine. ,vol. 367, pp. 135- 145 ,(2012) , 10.1056/NEJMOA1201248
Angela C. Burman, Tatjana Banovic, Rachel D. Kuns, Andrew D. Clouston, Amanda C. Stanley, Edward S. Morris, Vanessa Rowe, Helen Bofinger, Renae Skoczylas, Neil Raffelt, Olivier Fahy, Shaun R. McColl, Christian R. Engwerda, Kelli P. A. McDonald, Geoffrey R. Hill, IFNγ differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract Blood. ,vol. 110, pp. 1064- 1072 ,(2007) , 10.1182/BLOOD-2006-12-063982
Usama Gergis, Jon Arnason, Rhonda Yantiss, Tsiporah Shore, Usama Wissa, Eric Feldman, Thasia Woodworth, Effectiveness and Safety of Tocilizumab, an Anti–Interleukin-6 Receptor Monoclonal Antibody, in a Patient With Refractory GI Graft-Versus-Host Disease Journal of Clinical Oncology. ,vol. 28, ,(2010) , 10.1200/JCO.2010.29.1682
Isao Tawara, Motoko Koyama, Chen Liu, Tomomi Toubai, Dafydd Thomas, Rebecca Evers, Peter Chockley, Evelyn Nieves, Yaping Sun, Kathleen P. Lowler, Chelsea Malter, Norihiro Nishimoto, Geoffrey R. Hill, Pavan Reddy, Interleukin-6 Modulates Graft-versus-Host Responses after Experimental Allogeneic Bone Marrow Transplantation Clinical Cancer Research. ,vol. 17, pp. 77- 88 ,(2011) , 10.1158/1078-0432.CCR-10-1198
Sung Won Choi, Thomas Braun, Lawrence Chang, James L M Ferrara, Attaphol Pawarode, John M Magenau, Guoqing Hou, Jan H Beumer, John E Levine, Steve Goldstein, Daniel R Couriel, Keith Stockerl-Goldstein, Oleg I Krijanovski, Carrie Kitko, Gregory A Yanik, Michael H Lehmann, Isao Tawara, Yaping Sun, Sophie Paczesny, Markus Y Mapara, Charles A Dinarello, John F DiPersio, Pavan Reddy, Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial The Lancet Oncology. ,vol. 15, pp. 87- 95 ,(2014) , 10.1016/S1470-2045(13)70512-6
Glen A Kennedy, Antiopi Varelias, Slavica Vuckovic, Laetitia Le Texier, Kate H Gartlan, Ping Zhang, Gethin Thomas, Lisa Anderson, Glen Boyle, Nicole Cloonan, Justine Leach, Elise Sturgeon, Judy Avery, Stuart D Olver, Mary Lor, Ashish K Misra, Cheryl Hutchins, A James Morton, Simon TS Durrant, Elango Subramoniapillai, Jason P Butler, Cameron I Curley, Kelli P A MacDonald, Siok-Keen Tey, Geoffrey R Hill, Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial. Lancet Oncology. ,vol. 15, pp. 1451- 1459 ,(2014) , 10.1016/S1470-2045(14)71017-4
Parameswaran Hari, William R. Drobyski, Marcelo Pasquini, Kathy Kovatovic, Jeanne Palmer, J. Douglas Rizzo, Ayman Saad, Wael Saber, Tocilizumab for the Treatment of Steroid Refractory Graft-versus-Host Disease Biology of Blood and Marrow Transplantation. ,vol. 17, pp. 1862- 1868 ,(2011) , 10.1016/J.BBMT.2011.07.001